Hiroyo Yoshino Selected Research

Hiroyo Yoshino Research Topics

Disease

21	Parkinson Disease (Parkinson's Disease) 01/2022 - 02/2006
14	Parkinsonian Disorders (Parkinsonism) 04/2021 - 02/2006
6	Cognitive Dysfunction 04/2021 - 04/2014
4	Dementia (Dementias) 12/2020 - 08/2006
2	Psychotic Disorders (Schizoaffective Disorder) 04/2021 - 08/2006
2	Dystonia (Limb Dystonia) 08/2018 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014 - 01/2013
1	Autonomic Nervous System Diseases (Dysautonomia) 04/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2019
1	Tauopathies 12/2019
1	Frontotemporal Dementia (Semantic Dementia) 12/2019
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019
1	Synucleinopathies 01/2019
1	Dopa-responsive Dystonia 08/2018
1	Multiple System Atrophy 01/2018
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 01/2018
1	Cerebral Infarction 01/2017
1	CADASIL 01/2017
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2017
1	Neurodegeneration with brain iron accumulation (NBIA) 05/2015
1	Intellectual Disability (Idiocy) 05/2015
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 05/2013
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2013
1	Corticobasal Degeneration 01/2013
1	REM Sleep Behavior Disorder 01/2011
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 07/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2009

Drug/Important Bio-Agent (IBA)

8	Levodopa (L Dopa)FDA LinkGeneric 04/2021 - 12/2010
6	Phosphotransferases (Kinase)IBA 04/2021 - 02/2007
5	Leucine (L-Leucine)FDA Link 04/2021 - 02/2007
5	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2015
4	alpha-SynucleinIBA 12/2020 - 02/2006
3	NucleotidesIBA 01/2020 - 05/2009
3	SynucleinsIBA 12/2019 - 05/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2019 - 01/2013
2	IronIBA 01/2017 - 05/2015
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2011 - 08/2006
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 04/2021
1	TensinsIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	C 73IBA 12/2020
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2020
1	SaposinsIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 12/2019
1	Amyloid beta-PeptidesIBA 12/2019
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	Guanosine Triphosphate (GTP)IBA 08/2018
1	Ubiquinone Q2IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	polyglutamineIBA 07/2014
1	Glucosylceramidase (Glucocerebrosidase)IBA 04/2014
1	ProgranulinsIBA 01/2013
1	AphidicolinIBA 07/2010
1	Antipsychotic Agents (Antipsychotics)IBA 08/2009
1	Lithium Carbonate (Eskalith)FDA LinkGeneric 08/2009
1	Amino Acids FDA Link 02/2009